Pathologic complete response and overall survival in breast cancer subtypes in stage III inflammatory breast cancer-Reference-Cited by-同舟云学术

Pathologic complete response and overall survival in breast cancer subtypes in stage III inflammatory breast cancer

Published:2019-04-10 Issue:1 Volume:176 Page:217-226
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

van Uden Dominique J. P.^ORCID,van Maaren Marissa C.,Bult Peter,Strobbe Luc J. A.,van der Hoeven J. J. M.,Blanken-Peeters Charlotte F. J. M.,Siesling Sabine,de Wilt Johannes H. W.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-019-05219-7.pdf

Reference32 articles.

1. Fouad TM et al (2015) Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis. Breast Cancer Res Treat 152(2):407–416

2. van Uden DJP, van Laarhoven HWM, Westenberg AH, de Wilt JHW, Blanken-Peeters CFJM (2015) Inflammatory breast cancer: an overview. Critical Reviews in Oncology/Hematology 93(2):116–126

3. van Uden DJP, Bretveld R, Siesling S, de Wilt JHW, Blanken-Peeters CFJM (2017) Inflammatory breast cancer in the Netherlands; improved survival over the last decades. Breast Cancer Res Treat 162(2):365–374

4. Dawood S et al (2011) International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment. Ann Oncol 22(3):515–523

5. Carey LA et al (2006) Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295(21):2492–2502

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment Response, Tumor Infiltrating Lymphocytes and Clinical Outcomes in Inflammatory Breast Cancer–Treated with Neoadjuvant Systemic Therapy;Cancer Research Communications;2024-01-24

2. Machine learning prediction of pathological complete response and overall survival of breast cancer patients in an underserved inner-city population;Breast Cancer Research;2024-01-10

3. Clinical outcomes after 1 versus 2-3 lines of neoadjuvant therapy in stage III inflammatory breast cancer;Breast Cancer Research and Treatment;2023-12-28

4. Preoperative Radiation Therapy for Chemorefractory Localized Inflammatory Breast Cancer;Practical Radiation Oncology;2023-11

5. Machine learning prediction of pathological complete response and overall survival of breast cancer patients in an underserved inner-city population;2023-09-29